General Announcement::Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate in India

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
11-Jul-2019 11:37:28
Status
New
Announcement Sub Title
Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate in India
Announcement Reference
SG190711OTHRU29R
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
11/07/2019 08:56:00
Description (Please provide a detailed description of the event in the box below)
Glenmark & Torrent sign licensing agreement for co-marketing of Remogliflozin Etabonate in India

Attachments

SGX_11072019.pdf
Total size =3345K